Suchergebnisse - "Bertsias, Antonios"

PubPharm (49)

1

Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients : a prospective cohort study

enthalten in: Rheumatology international | 2024

von Flouri, I. | Goutakoli, P. | Repa, A. | +8

2

Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis

enthalten in: RMD open | 2024

von Bertsias, A. | Flouri, I. | Repa, A. | +5

3

A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients

enthalten in: Cells | 2023

von Goutakoli, P. | Papadaki, G. | Repa, A. | +10

4

Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study

enthalten in: Rheumatology international | 2023

von Flouri, I. | Goutakoli, P. | Repa, A. | +8

5

Ocular trauma, visual acuity related to time of referral and psychosocial determinants, during COVID‑19 pandemic : A prospective study

enthalten in: Experimental and therapeutic medicine | 2023

von Kyriakaki, E. | Detorakis, E. | Bertsias, A. | +5

6

Clinical and Social Features of Patients with Eye Injuries Admitted to a Tertiary Hospital : A Five-Year Retrospective Study from Crete, Greece

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Kyriakaki, E. | Detorakis, E. | Bertsias, A. | +4

7

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose : a 5-year cohort study

enthalten in: Arthritis research & therapy | 2022

von Bertsias, A. | Avgoustidis, N. | Papalopoulos, I. | +6

8

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study

enthalten in: Arthritis Research & Therapy | 2022

von Bertsias, A. | Avgoustidis, N. | Papalopoulos, I. | +6

9

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study

enthalten in: Arthritis Research & Therapy | 2022

von Bertsias, A. | Avgoustidis, N. | Papalopoulos, I. | +6

10

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment : A real-life, multicentre observational study

enthalten in: Frontiers in immunology | 2022

von Nikoloudaki, M. | Nikolopoulos, D. | Koutsoviti, S. | +13

1
2
3
4
5
Nächster »
[5]